↓ Skip to main content

Bispecific CD3-HAC carried by E1A-engineered mesenchymal stromal cells against metastatic breast cancer by blocking PD-L1 and activating T cells

Overview of attention for article published in Journal of Hematology & Oncology, April 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
35 Mendeley